Authors:
Reshetnyak, TM
Patrushev, LI
Stukacheva, EA
Miroshnikov, AI
Tikhonova, TL
Nasonov, EL
Alekberova, ZS
Citation: Tm. Reshetnyak et al., Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome, TERAPEVT AR, 72(5), 2000, pp. 34-38
Authors:
Alekberova, ZS
Popkova, TV
Nasonov, EL
Reshetnyak, TM
Ozerova, IN
Perova, NV
Citation: Zs. Alekberova et al., Lipid-protein parameters of blood cholesterol transport in systemic lupus erythematosus, TERAPEVT AR, 71(5), 1999, pp. 34-38
Authors:
Reshetnyak, TM
Alekberova, ZS
Nasonova, VA
Citation: Tm. Reshetnyak et al., Administration of vasaprostan in patients with systemic lupus erythematosus with antiphospholipid syndrome, TERAPEVT AR, 71(5), 1999, pp. 40-47
Authors:
Kozyr, AV
Kolesnikov, AV
Aleksandrova, ES
Sashchenko, LP
Gnuchev, NV
Favorov, PV
Kotelnikov, MA
Iakhnina, EI
Astsaturov, IA
Prokaeva, TB
Alekberova, ZS
Suchkov, SV
Gabibov, AG
Citation: Av. Kozyr et al., Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases, APPL BIOC B, 75(1), 1998, pp. 45-61
Authors:
Resetnyak, TM
Alekberova, ZS
Nasonov, EL
Nasonova, VA
Citation: Tm. Resetnyak et al., Combined therapy of thrombocytopenia in SLE patient with antiphospholipid syndrome, TERAPEVT AR, 70(11), 1998, pp. 67-68